The healthcare provider Cancer Treatment Centers of America has recently teamed up with some big names in order to spread awareness about prostate cancer and encourage getting screened. Famous coaches and athletes from the NFL’s Alumni Association have partnered with Cancer Treatment Centers of America and LabCorp to educate men, especially those over 40 years old, about the risk of prostate cancer. The collaborative effort also seeks to make screenings more widely accessible.
A total of 2,000 men who meet the requirements will be able to receive a free prostate cancer screening at one of the hundreds of LabCorp locations throughout the United States. After the initial spots have been taken, the campaign will continue by offering additional screenings at a discounted rate of $25 for other individuals. The special screening period will last for six months.
Public service announcements will air on television and include NFL coaches who will speak on the importance of the screenings. In addition, major events will occur at four of the five Cancer Treatment Centers of America locations as part of the campaign. Events will include speaking segments from former NFL players and cancer treatment specialists.
Cancer Treatment Centers of America was founded in 1988 by Richard J Stephenson. The limited treatment options available at the time ultimately inspired Stephenson to create a medical service dedicated to oncology. The organization now consists of five different hospitals across the United States, with the headquarters located in Boca Raton, Florida.
Being solely focused on a specific ailment allows Cancer Treatment Centers of America to offer some of the most comprehensive options available. Patients in need of treatment will have a personalized approach to a cure that can include surgery, radiation treatment, and chemotherapy. Specialists working with the organization also help each patient treat the symptoms of cancer treatment through the most effective methods.
Follow Cancer Treatment Centers of America on LinkedIn, here.